Lv1
40 积分 2021-08-24 加入
569 The Leuven PARPi benefit test as improved approach for prediction of PARPi benefit in the PAOLA-1/ENGOTov25 trial
8个月前
已完结
子宫内膜癌分子检测：SGO临床实践声明
11个月前
已完结
Ovarian cancer onset across different<i>BRCA</i>mutation types: a view to a more tailored approach for<i>BRCA</i>mutated patients
1年前
已完结
Ovarian cancer onset across differentBRCAmutation types: a view to a more tailored approach forBRCAmutated patients
1年前
已完结
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status
1年前
已完结
Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instability
1年前
已完结
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
1年前
已完结
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
1年前
已完结
[China guideline for the screening and early detection of prostate cancer (2022, Beijing)]
1年前
已完结
Use of plant chloroplast RNA-binding proteins as orthogonal activators of chloroplast transgenes in the green alga Chlamydomonas reinhardtii
2年前
已完结
皖公网安备34019202002308
